Drug-Metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 9, 2000, Pages 857-861

  Nebert, D W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Ecogenetics; Environmental susceptibility genes; Gene polymorphisms; Individual risk assessment of toxicity and cancer; Pharmacogenetics; Pharmacogenomics; Phase I and Phase II drug metabolism; The Human Genome Project

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DRUG METABOLIZING ENZYME; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOIC ACID RECEPTOR; TOXIC SUBSTANCE;

AGONIST; ARTICLE; BINDING COMPETITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVATION; DRUG DEGRADATION; DRUG METABOLISM; ENVIRONMENT; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIGAND BINDING; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALIA; EUKARYOTA; PROKARYOTA;

EID: 0033759620     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.124     Document Type: Article

References (36)

1. Moderne Probleme der Humangenetik
2. Pharmacogenetics:65 candles on the cake
3. Genetic variation as a guide to drug development
4. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase
5. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist?
6. Reflections and latest thoughts on the evolution of drug metabolism
7. Regulation of gene expression by reactive oxygen
8. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis
9. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer
10. Growth signal pathways
11. Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions
12. Drug-metabolizing enzymes in ligand-modulated transcription
13. Polymorphisms in drug-metabolizing enzymes: What is their clinical significance and why do they exist?
14. Biochemistry and molecular biology of the human CYP2C subfamily
15. Cytochrome P450 2C is an EDHF synthase in coronary arteries
16. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: A potential unifying mechanism for its altered biotransformation and toxicity
17. Cytochrome P450: Evolution and functional diversity
18. Markedly increased constitutive CYP1A1 mRNA levels in the fertilized ovum of the mouse
19. Receptors find work as guides. Research news
20. Tyrosine kinase inhibition: An approach to drug development
21. BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites
22. Toxicity of angular furanocoumarins to swallowtail butterflies: Escalation in a coevolutionary arms race?
23. Black swallowtail (Papilio polyxenes) alleles encode cytochrome P450s that selectively metabolize linear furanocoumarins
24. Interethnic factors affecting drug response
25. Pharmacogenetics: The slow, the rapid, and the ultrarapid
26. Pharmacogenetics
27. 2000, Suggestions for the nomenclature of human alleles: Relevance to ecogenetics, pharmacogenetics and molecular epidemiology
28. Evolution of the P450 gene superfamily: Animal-plant ″warfare,″ molecular drive, and human genetic differences in drug oxidation
29. Populations and genetic polymorphisms
30. Inactivating mutations in the 25-hydroxyvitamin D3 1a-hydroxylase gene in patients with pseudovitamin D-deficiency rickets
31. Genetics of vitamin D 1a-hydroxylase deficiency in 17 families
32. The molecular basis of Sjogren-Larsson syndrome: Mutation analysis of the fatty aldehyde dehydrogenase gene
33. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21
34. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase
35. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene